Hildred Capital Management Completes Strategic Investment in AleraCare

Capital will be used by AleraCare to double clinical capacity over the next 24-months in an effort to provide even greater support to patients and providers

NEW YORK--(BUSINESS WIRE)--Hildred Capital Management, (“Hildred” or the “Firm”) a healthcare-focused private equity firm that specializes in partnering with middle-market companies to help scale their businesses and create value, today announced that it has completed a strategic investment in AleraCare, (the “Company”) a leading provider of infusion and specialty pharmacy services across the country.

Founded in 2019, AleraCare’s core lines of business include ambulatory infusion centers, home infusion therapy, specialty pharmacy and compounding pharmacy. Administered by best-in-class clinicians at convenient, accessible, patient-first locations, AleraCare is focused on maintaining trusted-partner status with physicians, payors and pharmaceutical manufacturer partners. The Company has rapidly expanded to over 35 ambulatory infusion centers across the country and has achieved success to date by being a provider-of-choice for infusion services to high-need and medically complex populations.

“Hildred brings a wealth of experience to AleraCare given the team’s deep operational expertise and proven record of helping healthcare service providers create long-term value,” said Russ Corvese, Chief Executive Officer of AleraCare. “We are thrilled to partner with the team at Hildred and greatly appreciate their support as we continue our mission of satisfying patients’ and physicians’ expectations and being recognized as a trusted partner and preferred destination for innovative, accessible and advanced patient-focused site of care services.”

“We seek to back exceptional management teams in structurally attractive healthcare sectors that have sizeable market potential, excellent growth prospects, attractive innovation opportunities and manageable pricing trends and competition,” said Andrew Goldman, Co-Founder and Managing Partner of Hildred. “AleraCare meets this criteria and we believe the Company is poised for even greater success.”

Stephen Hallenbeck, Managing Director at Hildred, added, “Russ and the entire AleraCare team have done a remarkable job of building what we believe is a fantastic business that possesses significant growth potential. We are looking forward to partnering with them to help further scale the business and provide strategic support, as appropriate.”

AleraCare will use the capital provided by Hildred to further enhance its platform for all existing and future patients as it continues to grow its physical footprint, and advance physician-coordinated care standards through comprehensive and convenient infusion service offerings.

Holland & Knight served as legal counsel for Hildred Capital. K&L Gates and Kudman Law served as legal counsel for AleraCare and Cantor Fitzgerald served as the Company’s exclusive financial advisor.

About Hildred Capital Management

Hildred Capital Management is a healthcare-focused private equity firm that seeks opportunities to create value in middle-market companies. The Firm specializes in partnering with management teams to help them scale their platforms, generate earnings growth, promote strategic and operational improvements, generate business development, and drive multiple expansion. For more information, please visit www.hildredcapital.com and follow the Firm on LinkedIn.

About AleraCare

AleraCare is a leading provider of infusion treatments and pharmacy services for high-need and medically complex populations. The Company’s core lines of business include AleraCare advanced home infusion, AleraCare advanced specialty pharmacy, and AleraCare advanced compounding pharmacy. AleraCare provides care to patients in over 35 locations across eight states throughout the United States, including Arizona, California, Colorado, Idaho, New Mexico, Oregon, Utah and Washington. For more information, please visit www.aleracare.com and follow the Company on LinkedIn.